Daigneault Alessandra
Insider CIK 1864648 · NRXP General Counsel & Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NRXP NRX Pharmaceuticals, Inc. | A Award deriv | 2021-09-02 | 2021-11-02 | 7,502 | — | $0 | 33,603 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | A Award deriv | 2021-09-02 | 2021-11-02 | 10,496 | — | $0 | 26,101 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | C Conversion deriv | 2021-09-02 | 2021-11-02 | 20,666 | $3.07 | $63.4K | 28,934 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | C Conversion deriv | 2021-09-02 | 2021-11-02 | 28,916 | $3.07 | $88.8K | 71,924 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | M Exercise | 2021-09-02 | 2021-11-02 | 18,420 | $3.07 | $56.5K | 18,420 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | M Exercise | 2021-09-02 | 2021-11-02 | 13,164 | $3.07 | $40.4K | 31,584 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | S Sale | 2021-08-23 | 2021-11-02 | 33,715 | $13.11 | $442.0K | 0 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | A Award deriv | 2021-08-19 | 2021-11-02 | 15,605 | — | $0 | 15,605 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | C Conversion deriv | 2021-08-19 | 2021-11-02 | 43,000 | $3.07 | $132.0K | 100,840 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | M Exercise | 2021-08-19 | 2021-11-02 | 27,395 | $3.07 | $84.1K | 33,715 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | A Award deriv | 2021-05-24 | 2021-06-10 | 143,840 | — | $0 | 143,840 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | A Award deriv | 2021-05-24 | 2021-06-10 | 148,800 | — | $0 | 148,800 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | A Award deriv | 2021-05-24 | 2021-06-10 | 49,600 | — | $0 | 49,600 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | A Award | 2021-05-24 | 2021-06-10 | 6,320 | — | $0 | 6,320 | SEC↗ |